Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events

Luminex Corporation (NASDAQ: LMNX) announced today that Public Health Wales is using Luminex's CE marked xTAG Gastrointestinal Pathogen Panel (GPP) for outbreak investigation activities during Olympic and Paralympic training and events taking place in Wales. Results of a substantial diagnostic validation of the GPP test conducted by The Public Health Wales Microbiology laboratory team at the University Hospital of Wales, Cardiff, are anticipated to be published in a peer reviewed journal

Luminex's xTAG GPP received CE mark in 2011 and is the most comprehensive test available to diagnose gastrointestinal infections. xTAG GPP simultaneously detects fifteen of the most common disease-causing pathogens, including viral, bacterial and parasitic infections, such as norovirus, C. difficile, toxigenic strains of E. coli, Campylobacter, Cryptosporidium, and Salmonella, all within 5-6 hours.  Innovations in diagnostic technology like xTAG GPP provide the potential for rapid identification of the cause of outbreaks of gastrointestinal infection and improved patient care.

"We are very pleased with the performance of the assay to date in our validations comparing it to our traditional methods," said Michael Perry, Clinical Scientist within the National Molecular Diagnostics Laboratory, Public Health Wales. "The ability to generate answers during a single work shift for a majority of the pathogens involved in gastroenteritis, compared to traditional methods which would have taken 2 days in some cases and much more work to return the same amount of information, is a significant advance."

"Seeing the contribution of our technology innovations and ability to make a positive impact in public health makes us very proud," said Patrick J. Balthrop, president and CEO of Luminex. "We are pleased to work with thought leaders like the Molecular Laboratory team at Public Health Wales, Cardiff, who continue to advance healthcare and public safety."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Luminex. (2019, June 19). Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events. News-Medical. Retrieved on April 13, 2024 from https://www.news-medical.net/news/20120806/Public-Health-Wales-uses-Luminexs-xTAG-GPP-for-outbreak-investigations-during-Olympic-events.aspx.

  • MLA

    Luminex. "Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events". News-Medical. 13 April 2024. <https://www.news-medical.net/news/20120806/Public-Health-Wales-uses-Luminexs-xTAG-GPP-for-outbreak-investigations-during-Olympic-events.aspx>.

  • Chicago

    Luminex. "Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events". News-Medical. https://www.news-medical.net/news/20120806/Public-Health-Wales-uses-Luminexs-xTAG-GPP-for-outbreak-investigations-during-Olympic-events.aspx. (accessed April 13, 2024).

  • Harvard

    Luminex. 2019. Public Health Wales uses Luminex's xTAG GPP for outbreak investigations during Olympic events. News-Medical, viewed 13 April 2024, https://www.news-medical.net/news/20120806/Public-Health-Wales-uses-Luminexs-xTAG-GPP-for-outbreak-investigations-during-Olympic-events.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Luminex announces group B strep as fifth assay planned for launch menu of ARIES